Skip to main content
. 2021 Jul 26;38(3):461–472. doi: 10.5114/ada.2021.107933

Figure 3 A.

Figure 3 A

Immunodetection of selected neuropeptides and their receptors in positive IHC labelling is represented in brown. The left panel represents healthy controls, middle – representative epidermis of SM/CM patients, right – representative dermis of SM/CM patients. Braces mark the range of pigment; arrows indicate positive NMC cells. Haematoxylin stained samples, where primary antibodies omitted, serve as negative controls. See Tables 3 or 4 for details.